A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis
Clinical trial NCT04152382 · TERMINATED
Trial details
- NCT number
- NCT04152382
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2022-02-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.